Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271161![]() (7-(2,3-difluorobenzenesulfonyl)-4-(2,2-dimethylmor...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271162![]() (7-(2-fluoro-4-methoxybenzenesulfonyl)-2-methyl-4-[...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271179![]() (7-(2-fluorobenzenesulfonyl)-N2-methyl-4-(2-methylm...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271169![]() (7-(2-fluorobenzenesulfonyl)-2-methyl-4-[(2R)-2-(tr...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271163![]() (7-(4-chloro-2-fluorobenzenesulfonyl)-2-methyl-4-[(...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271119![]() (7-(benzenesulfonyl)-4-(2-methylmorpholin-4-yl)-2-(...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271121![]() (7-(benzenesulfonyl)-2-methyl-4-(propan-2-yloxy)-5H...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271164![]() (7-(2,4-difluorobenzenesulfonyl)-2-methyl-4-[(2S)-2...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271165![]() (7-(2,3-difluorobenzenesulfonyl)-2-methyl-4-[(2S)-2...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271170![]() (7-(2-fluorobenzenesulfonyl)-2-methyl-4-[(2R)-2-(tr...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271115![]() (4-(2-methylmorpholin-4-yl)-7-(phenylsulfanyl)-5H-p...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271177![]() (7-(4-chloro-2-fluorobenzenesulfonyl)-2-methyl-4-[(...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271182![]() (7-(2-fluorobenzenesulfonyl)-2-(methylsulfanyl)-4-[...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271098![]() (7-(benzenesulfonyl)-4-[(2R,5R)-2,5-dimethylmorphol...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271111![]() (7-(2-fluorobenzenesulfonyl)-2-methyl-4-[2-(trifluo...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271173![]() (7-(2,5-difluorobenzenesulfonyl)-2-methyl-4-[(2S)-2...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271146![]() (7-(3-fluorobenzenesulfonyl)-4-(2-methylmorpholin-4...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271160![]() (7-(2-fluorobenzenesulfonyl)-2-methyl-4-[(2S)-2-(tr...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271166![]() (7-(2,6-difluorobenzenesulfonyl)-4-(2,2-dimethylmor...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271171![]() (7-(2-fluorobenzenesulfonyl)-2-methyl-4-[(2R)-2-(tr...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271172![]() (7-(2-fluoro-4-methoxybenzenesulfonyl)-2-methyl-4-[...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM270890![]() (7-(benzenesulfonyl)-4-(piperidin-1-yl)-5H-pyrrolo[...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271183![]() (7-(2-fluorobenzenesulfonyl)-2-methyl-4-[2-methyl-2...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271088![]() (4-cyclopentyl-7-(3-fluorobenzenesulfonyl)-2-methyl...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271112![]() (7-(2-fluoro-4-methoxybenzenesulfonyl)-2-methyl-4-[...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271113![]() (4-[(2R,5R)-2,5-dimethylmorpholin-4-yl]-7-(2-fluoro...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271175![]() (4-[(2,2-dimethyloxan-3-yl)oxy]-7-(2-fluorobenzenes...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271147![]() (7-(2-fluoro-5-methoxybenzenesulfonyl)-2-methyl-4-(...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271077![]() (7-(benzenesulfonyl)-4-(2-ethylthiomorpholin-4-yl)-...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271174![]() (7-(2,6-Difluorobenzenesulfonyl)-2-methyl-4-[(2S)-2...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271159![]() (7-(4-chloro-2-fluorobenzenesulfonyl)-4-(2,2-dimeth...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271142![]() (7-(2,6-difluorobenzenesulfonyl)-2-methyl-4-(2-meth...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271067![]() (7-(benzenesulfonyl)-4-N-ethyl-4-N-(oxan-4-ylmethyl...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271178![]() (7-(2-fluorobenzenesulfonyl)-4-[(2R)-2-(fluoromethy...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271155![]() (7-(2-fluorobenzenesulfonyl)-2-methyl-4-[(1,1,1-tri...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271143![]() (7-(2,4-difluorobenzenesulfonyl)-2-methyl-4-(2-meth...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271158![]() (3-(benzenesulfonyl)-7-(2,2-dimethylmorpholin-4-yl)...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271020![]() (7-(benzenesulfonyl)-4-[(2R,6S)-2,6-dimethylmorphol...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271097![]() (7-(2-fluorobenzenesulfonyl)-2-methyl-4-[(2S)-2-met...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271062![]() (4-(4,4-difluoropiperidin-1-yl)-7-(3-fluorobenzenes...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271065![]() (7-(benzenesulfonyl)-4-[2-(propan-2-yl)morpholin-4-...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271057![]() (7-(2-fluorobenzenesulfonyl)-2-methyl-4-{6-oxa-9-az...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271085![]() (US10059713, Example 206) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271109![]() (7-(benzenesulfonyl)-4-(1-cyclopropylethoxy)-2-meth...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271103![]() (7-(2-fluorobenzenesulfonyl)-2-methyl-4-(prop-1-en-...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271117![]() (7-(2-fluorobenzenesulfonyl)-2-methyl-4-{5-oxa-8-az...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271151![]() (7-(2-fluorobenzenesulfonyl)-2-methyl-4-(propan-2-y...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271075![]() (7-(benzenesulfonyl)-4-(2-methylthiomorpholin-4-yl)...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271168![]() (7-(2,5-difluorobenzenesulfonyl)-4-(2,2-dimethylmor...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM271056![]() (US10059713, Example 175) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8 | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Co., Ltd US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 1157 total ) | Next | Last >> |